...
首页> 外文期刊>Neurology: Official Journal of the American Academy of Neurology >Prescription of antihypertensive medication at discharge influences survival following stroke
【24h】

Prescription of antihypertensive medication at discharge influences survival following stroke

机译:抗高血压药物的处方中风后放电影响生存

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectiveTo investigate the risk of death from cardiovascular disease between patients who were and were not prescribed antihypertensive medication following stroke or TIA.MethodsThis was a large cohort study using routinely collected prospective data from the Australian Stroke Clinical Registry. Patients registered between 2009 and 2013 who were discharged to the community or rehabilitation were included. Cases were linked to the National Death Index to determine the date and cause of death. Propensity score matching with stratification was utilized to compare between similar subgroups of patients. Multivariable competing risks regression, with noncardiovascular death as a competing risk, was conducted to investigate the association between the prescription of antihypertensive medications and cardiovascular death at 180 days after admission.ResultsAmong 12,198 patients from 40 hospitals, 70% were prescribed antihypertensive medications. Patients who were older, were treated in a stroke unit, and had better socioeconomic position were more often discharged from hospital with an antihypertensive medication. Including only patients within propensity score quintiles with acceptable levels of balance in covariates between groups (n = 8,786), prescription of antihypertensive medications was associated with a 23% greater reduction in the subhazard of cardiovascular death compared to those who were not prescribed these agents (subhazard ratio 0.77; 95% confidence interval 0.61 to 0.97).ConclusionsPeople who are prescribed antihypertensive medications at discharge from hospital after a stroke or TIA demonstrate better cardiovascular and all-cause survival outcomes than those not prescribed these agents.
机译:目的探讨死亡的风险心血管疾病患者之间并没有规定抗高血压药物治疗中风或TIA后。是一个大型队列研究使用常规收集潜在的来自澳大利亚的数据中风临床注册表。排放到2009年和2013年之间社区或康复了。与全国死亡指数确定死亡的日期和原因。分数与分层匹配是利用之间的比较相似的子组的患者。多变量回归竞争风险,noncardiovascular死亡风险,竞争进行的调查之间的关系抗高血压药物的处方和心血管死亡后180天入学。医院,70%是处方抗高血压的药物。治疗在卒中单元,为好社会经济地位更经常排放从医院抗高血压药物治疗。倾向分数昆泰与可以接受的水平平衡之间的共组(n =8786),处方抗高血压药物高23%减少心血管的subhazard死亡比那些没有规定这些代理(subhazard比0.77;置信区间0.610.97)。抗高血压药物治疗出院医院中风后或TIA演示更好心血管和全因生存的结果比那些没有规定这些代理。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号